BAMF Health
BAMF Health is achieving intelligence-based precision medicine through molecular imaging and molecular targeted radiation therapy.
06/16/2026
FutureSolve is back! And this year it's bigger and better than ever.
The high school summer internship program is a collaboration between BAMF, Kent ISD, Ferris State University, and—new this year—Steelcase and Blox.
Our team has some exciting projects lined up for students, and their ideas have the potential to make a profound impact on our organization and patients.
Thank you to Andy McLean, Clay McNamara, Shelby Simon, Marissa Saenz, and Christine VanTimmeren for mentoring students this year!
Learn more: https://www.bamfhealth.com/news/futuresolve-student-intern-program-kicks-off-third-year-at-bamf/
The man, the myth, the legend talks about the myths, the facts, and the impact of radiopharmaceutical clinical trials.
Our VP of Clinical Trials, Dan Rogers, joins The BAMF Health Podcast to talk about the role clinical trials play in advancing medicine, the complexities associated with radiopharmaceutical trials, and the challenges the industry faces.
Listen now: https://youtu.be/KC2xJQKwUDA
06/04/2026
Angela has been battling lung cancer for six years, and now it’s metastatic. Chemotherapy helped a little, but the side effects were brutal and debilitating.
Her options were running out, so her doctor referred her to BAMF for a brand-new clinical trial. She’s now the first person in the world to participate in an innovative radiopharmaceutical therapy trial!
“I couldn’t get on the phone fast enough to come here. I wanted to get started right away.” - Angela
Learn more about her journey to BAMF and the Radiopharm Theranostics trial she’s participating in:
Lung Cancer Patient is First in the World to Participate in New Therapy Trial Angela is the first person in the world to participate in a new clinical trial exploring an investigational radiopharmaceutical therapy.
06/02/2026
He's one in a million.
At 16 years old, Sam (seen on the right) was diagnosed with a rare cancer that affects one in a million people. It's called epithelioid hemangioendothelioma, or EHE.
It's incredibly difficult to detect and even more complex to treat. But he's hoping his participation in a clinical trial at BAMF will help improve detection for others like him in the future.
Watch Sam's inspiring story: https://www.wzzm13.com/article/news/local/one-in-a-million-west-mi-man-with-rare-cancer-joins-clinical-trial-to-help-others/69-56f2848c-cef5-4ac2-bd83-03cf8ed7fc2d?utm_medium=social&utm_source=facebook_13_On_Your_Side&utm_id=97757_v0_s00_e0_tv2_a1demo0dynkuks&fbclid=IwY2xjawSKhUpleHRuA2FlbQIxMQBicmlkETFEUVZYdVE4T0RWRXJVeTRtc3J0YwZhcHBfaWQQMjIyMDM5MTc4ODIwMDg5MgABHk4jagNNQ-jxEuWUED6dwumrxqRZa2nwumu_FSg2IsmUbeVMA-1P-yy2SZ4D_aem_EQ5tZyOWmOc0pG-7EidQ3Q
One in a million: West MI man with rare cancer joins clinical trial to help others Sam Mulder has lived with a rare, untreatable cancer for seven years. Now, he's turning his pain into progress for future patients.
Click here to claim your Sponsored Listing.
Category
Website
Address
109 Michigan Street NW, Suite 700
Grand Rapids, MI
49503
Opening Hours
| Monday | 9am - 5pm |
| Tuesday | 9am - 5pm |
| Wednesday | 9am - 5pm |
| Thursday | 9am - 5pm |
| Friday | 9am - 5pm |